A

Agilent Technologies' stock has experienced various events and movements in the past six months. As of May 4, 2026, the share price was $112.18, representing an increase of 3.52% over the past year, but the year-to-date total return for A stock is down 14.68%. Key corporate events included naming Michael Buckner as Chief Legal Officer, the announcement of the second-quarter fiscal year 2026 financial results release date, resolution of litigation between Axion BioSystems and Agilent Technologies, showcasing cancer research solutions at AACR 2026, the 2026 Annual General Meeting, participation in TD Cowen's 46th Annual Health Care Conference, the Q1 2026 Earnings Conference Call, and presenting at the 44th Annual J.P. Morgan Healthcare Conference. Agilent concluded its fiscal year 2025 with strong operational results, reporting revenue of $1.86 billion for the fourth quarter ended October 31, 2025.